The Year in Medicine — Dec. 05, 2005 — Page 1

Posted November 30, 2005 by Brian

The Year in Medicine — Dec. 05, 2005 — Page 1
Time – AIDS This was the year that the World Health Organization (WHO), under the banner of its innovative ‘3 by 5′ campaign, was supposed to put 3 million AIDS patients in the developing world on life-saving antiretroviral drugs. in the front seat of a car. ALZHEIMER’S One of the most tragic features of this neurological disease that the long goodbye of Alzheimer’s may begin even earlier than doctors

Descent into dementia: One familys struggle with Alzheimers disease

Posted November 30, 2005 by Brian

Descent into dementia: One familys struggle with Alzheimers disease
Standard-Journal – By Joe Conroy, Staff writer LEWISBURG Everyone has had an experience with an elderly family member. As they get on in years, loss of certain functions of the brain is a normal part of the aging process. and an acquired mental deficiency such as Alzheimers disease be differentiated?Bill Hahn of Lewisburg, whose wife Sylvia struggled with Alzheimers for 11 years, wasnt able to

Puskas fund to get 56,000 pounds from Real game 

Posted November 28, 2005 by Brian

Puskas fund to get 56,000 pounds from Real game 
Reuters via Yahoo! Australia & NZ News - Nov 04 7:09 AM
BUDAPEST, Nov 4 (Reuters) – A fund to pay for the hospital costs of ailing Hungarian soccer legend Ferenc Puskas is to receive 56,000 pounds ($99,430) from the organisers of a much criticised match between a Hungarian team and Real Madrid.Save to My Web

Painkiller aids elderly dementia patients

Posted November 28, 2005 by Brian

Painkiller aids elderly dementia patients
NDTV – They tended, for example, to spend less time in their rooms and more time watching television, listening to music, reading or performing work-like activities. bone fractures and nerve damage from diabetes. But Alzheimer ’s disease and other forms of dementia can get in the

Pain and Epilepsy Are Forecast to Become Fiercely Competitive Indications in the CNS Market, as Heavier Genericization  

Posted November 27, 2005 by Brian

Pain and Epilepsy Are Forecast to Become Fiercely Competitive Indications in the CNS Market, as Heavier Genericization  
[Press Release] Business Wire via Yahoo! Finance - Nov 02 7:10 AM
Research and Markets has announced the addition of The CNS Market OutSave to My Web

Alzheimer’s support group 

Posted November 26, 2005 by Brian

Alzheimer’s support group 
Daily Press - Nov 17 1:24 AM
Two Alzheimer’s support groups meet in the Williamsburg area, supporting families and friends caring for loved ones with the disease. The first group meets at 11 a.m. the first Tuesday of the month in the Alzheimer’s Association Williamsburg Branch office, 213 McLaws Circle, Suite 2B. Information: Stephanie Smith, 221-7272. The second meets at 2 p.m. the third Thursday of the month at Dominion Save to My Web

Statins May Slow the Effects of Alzheimer's Disease According to

Posted November 25, 2005 by Brian

Statins May Slow the Effects of Alzheimer's Disease According to
CCNMatthews (press release), Canada - Nov 18, 2005 Cholesterol-lowering drugs like statins were found to slow the progression of Alzheimer's disease (AD) in a new three year study of 342 AD patients (J. Neurol.

Clinic hosts Alzheimers talk

Posted November 25, 2005 by Brian

Clinic hosts Alzheimers talk
Corvallis Gazette-Times – Three neurologists at the Corvallis Clinic will lead a discussion about Alzheimers on Thursday from 6:30 to 7:30 p.m. in the Asbury Building Dining Room.The presentation coincides with National Alzheimers Disease Awareness Month.

Dementia treatments disappoint

Posted November 24, 2005 by Brian

Dementia treatments disappoint
San Mateo Daily Journal – Families battling Alzheimers disease and similar dementias increasingly are calling for a shot at riskier therapies that

Neurochem Starts EU Alzhemed Enrollment 

Posted November 23, 2005 by Brian

Neurochem Starts EU Alzhemed Enrollment 
AP via Yahoo! Finance - Nov 22 8:05 AM
Canadian biopharmaceutical company Neurochem Inc. said Tuesday that it started enrollment of a late-stage European clinical trial to test its Alzheimer’s disease treatment Alzhemed.Save to My Web

Next Page »

Alzheimers Disease